BLAIR WILLIAM & CO/IL - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$346,971
-32.9%
63,664
-17.4%
0.00%
-50.0%
Q2 2023$517,102
-25.7%
77,064
-2.3%
0.00%
-33.3%
Q1 2023$696,372
+27.9%
78,864
+10.7%
0.00%
+50.0%
Q4 2022$544,322
-0.1%
71,246
-6.9%
0.00%
-33.3%
Q3 2022$545,000
-8.6%
76,531
+3.9%
0.00%0.0%
Q2 2022$596,000
-71.6%
73,651
-51.4%
0.00%
-57.1%
Q1 2022$2,102,000
-55.6%
151,411
-10.2%
0.01%
-53.3%
Q4 2021$4,732,000
-45.0%
168,636
-33.4%
0.02%
-48.3%
Q3 2021$8,608,000
-24.5%
253,243
-9.2%
0.03%
-25.6%
Q2 2021$11,398,000
-1.4%
278,959
-2.9%
0.04%
-11.4%
Q1 2021$11,562,000
-56.3%
287,183
-35.7%
0.04%
-54.6%
Q4 2020$26,428,000
+26.4%
446,953
+3.9%
0.10%
+9.0%
Q3 2020$20,911,000
+134.1%
429,998
+132.9%
0.09%
+107.0%
Q2 2020$8,933,000
+172.8%
184,643
+56.6%
0.04%
+115.0%
Q1 2020$3,275,000
-51.1%
117,898
-47.4%
0.02%
-41.2%
Q4 2019$6,701,000
+86.9%
223,970
+93.1%
0.03%
+61.9%
Q3 2019$3,585,000116,0120.02%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2020
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders